European Association for the Study of Diabetes

The latest news from the EASD Annual Meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News Coverage

Novel epigenetic markers for type 2 diabetes risk detected in human liver

September 25, 2014
European researchers have identified epigenetic markers associated with type 2 diabetes risk in the tissue of the human liver, according to research…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke…
Meeting News CoveragePerspective

Cancer incidence in type 1 diabetes similar to general population

September 23, 2014
Site-specific cancer patterns in type 1 diabetes largely follow incidence in patients with type 2 diabetes, but more minimal, and do not drastically…
In the JournalsPerspective

Insulin degludec/liraglutide combo improved glucose in type 2 diabetes

September 23, 2014
A fixed-dose combination of insulin degludec and liraglutide improved plasma glucose for patients with type 2 diabetes who had not achieved glycemic…
Meeting News Coverage

Fixed-dose empagliflozin/linagliptin combinations improved HbA1c in type 2 diabetes

September 22, 2014
Whether already on metformin or drug-naive, patients with type 2 diabetes achieved better HbA1c control with fixed-dose combinations of…
Meeting News Coverage

Insulin pump use decreased all-cause mortality, fatal CVD risk

September 22, 2014
The use of insulin pumps resulted in a 29% reduction in all-cause mortality and a 43% reduction in the risk for fatal cardiovascular disease vs…
Meeting News Coverage

Omarigliptin efficacy, safety similar to sitagliptin

September 19, 2014
Similar efficacy and safety was found between once-weekly omarigliptin and once-daily sitagliptin among patients with type 2 diabetes, according to a…
Meeting News Coverage

Gestational diabetes increased type 2 diabetes, CV risk

September 18, 2014
The risk for type 2 diabetes and cardiovascular diseases is increased in women with pregnancies which were complicated by gestational diabetes and…
Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European…
Meeting News Coverage

Diabetic peripheral neuropathy increased risk for fall

September 18, 2014
Recent data presented at the 50th European Association for the Study of Diabetes Annual Meeting suggest that patients with diabetic peripheral…